Economic Aspects of Extreme Obesity in Adolescent

Summary

Obesity is one of the biggest public health challenges today and in the years to come, particularly due to its rising prevalence in children and adolescents. In addition to the increased health risks for each individual, obesity causes a tremendous economic burden on the healthcare system.

Here, the investigators will examine the impact of extreme obesity on healthcare utilization, costs, and health related quality of life in adolescents. The study is a subproject of the "Medical and psychosocial implications of adolescent extreme obesity - acceptance and effects of structured care study", short: "Youth with Extreme obesity Study (YES)", which aims at improving the medical care and social support structures for youth with obesity and extreme obesity in Germany. Obese youth and young adults (BMI ≥ 30kg/m2) between the ages of 14 and 24.9 years (initially up to 21 years) are eligible to participate. Participants will complete questionnaires to assess health related quality of life and utilization of healthcare. These questionnaires will be applied at baseline and then every 12 months (initially every 6 months) during health check-ups. As part of the other subprojects of YES, participants will be invited to complete further questionnaires and will be offered a thorough medical examination, medical care and psycho-social support.

The investigators expect to provide valid and up-to-date information on costs and health-related quality of life for obese adolescents. This information will help in the planning of useful and cost effective preventive and therapeutic strategies, and improve the medical care and support structures for obese adolescents.

Conditions

• Obesity
• Extreme Obesity

Sponsors & Collaborators

• University of Witten/Herdecke

  collaborator OTHER

• Charite University, Berlin, Germany

  collaborator OTHER

• University of Leipzig

  collaborator OTHER

• Universität Duisburg-Essen

  collaborator OTHER

• Helmholtz Zentrum München

  collaborator INDUSTRY

• University of Ulm

  lead OTHER

Principal Investigators

• Martin Wabitsch, Prof. Dr. med. · University of Ulm

• Susanna Wiegand, Dr. med. · Charite University, Berlin, Germany

• Thomas Reinehr, Prof. Dr. med. · University of Witten/Herdecke

• Johannes Hebebrand, Prof. Dr. med. · Universität Duisburg-Essen

• Wieland Kiess, Prof. Dr. med. · University of Leipzig

• Reinhard Holl, Prof. Dr. med. · University of Ulm

• Rolf Holle, Prof. Dr. · Helmholz Center Munich

Eligibility

Min Age

14 Years

Max Age

24 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2012-07-31

Primary Completion

2023-07-31

Completion

2023-07-31

Countries

• Germany

Study Locations